Severe idiopathic pulmonary fibrosis: A clinical approach

R. Lipsi, D. Mazzola, A. Caminati, D. Elia, C. Lonati, S. Harari

Research output: Contribution to journalArticlepeer-review


Idiopathic pulmonary fibrosis (IPF) is a devastating progressive disease associated with a high mortality rate. Novel antifibrotic therapies have been recently demonstrated to slow disease progression and improve survival. However, the management of IPF remains a difficult challenge, since lung complications can still occur, particularly in patients with advanced-stage disease. This paper highlights the most common complications and difficult tasks related to severe IPF such as acute exacerbation of the disease, development of lung cancer, rapid disease progression, and indication for lung transplantation.

Original languageEnglish
JournalEuropean Journal of Internal Medicine
Publication statusAccepted/In press - Jan 1 2018
Externally publishedYes


  • Acute exacerbation of IPF
  • Lung cancer
  • Lung transplantation
  • Nintedanib
  • Palliation
  • Pirfenidone

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Severe idiopathic pulmonary fibrosis: A clinical approach'. Together they form a unique fingerprint.

Cite this